Study: CBD usage linked to reduced medication intake

04/12/2023
A doctor holding a medicine

Introduction

Recent research has highlighted a remarkable trend: the consumption of CBD products is associated with a notable decrease in the use of both prescription and over-the-counter medications. This insight, derived from a study published in the journal 'Medical Cannabis and Cannabinoids', offers a new perspective on the potential health benefits and applications of CBD products.

Study overview: CBD's impact on medication use

Researchers from various respected institutions, including Tarleton State University, the University of Chicago, and Syzygy Research Solutions, conducted this comprehensive study. It focused on assessing the impact of long-term self-dosing of CBD on various health aspects, including its effect on the use of other medications.

Methodology and participant demographics

Participants aged 18 to 75 who had previously used unverified CBD products were selected for this observational study. They were provided with concentration-verified CBD products from 15 different vendors, which they used over a four-week period. The study sought to understand the primary reasons for CBD use, the symptoms it addressed, and its impact on general health and medication usage​.

Key findings: Reduction in medication use

The results of the study were significant. Thirty-one per cent of participants reported a decrease or complete cessation of over-the-counter drug use, while 19.2 per cent reported a reduction or stoppage in prescription drug use. This finding was most pronounced among those using CBD for chronic pain management. The study also observed a correlation between changes in CBD dosage and improvements in general health scores and symptom severity, leading to reduced medication usage​.

Primary reasons for CBD use

The most common reasons participants cited for using CBD were pain, mental health concerns (especially anxiety and stress), and sleep-related issues. These align with the broader understanding of CBD's therapeutic potential in addressing such health challenges​.

Comparative studies and broader context

This study's findings are consistent with other research demonstrating similar trends. Previous data have also shown a reduction in the use of prescription opioids and benzodiazepines among older adults using CBD-dominant cannabis products for medical purposes. Moreover, numerous studies have documented reductions in the consumption of prescription and over-the-counter medicines following the use of medical cannabis​.

Implications for future medical treatments

The implications of this study are far-reaching. It suggests that CBD could play a significant role in reducing dependency on traditional medications, especially for managing chronic pain, anxiety, and sleep disorders. This could lead to a shift in how certain health conditions are treated, with a potential increase in the use of CBD as a safer, non-addictive alternative to conventional medications.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

About the author

Robin Roy Krigslund-Hansen is the founder and CEO of Formula Swiss and is responsible for formulation. Since founding the company in 2013, he has written about hemp, CBD, and the cannabis industry. His perspective draws on building Formula Swiss, conversations with researchers, and supporting CBD research.

More about Robin Roy Krigslund-Hansen

Related products